Karolina Wosik
Kirkland, QC H2V2W6, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The efficacy and safety of etrasimod as a first-line advanced therapy for ulcerative colitis: prespecified and post hoc subgroup data from the ELEVATE UC clinical program.
Journal: Therapeutic advances in gastroenterology
Published: March 24, 2026
The Efficacy and Safety of Etrasimod in Mildly to Moderately Active Ulcerative Colitis: Results From the Phase II GLADIATOR Trial.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 22, 2025
Bowel urgency in ulcerative colitis is associated with clinical endpoints, health-related quality of life, and biomarkers: data from the etrasimod ELEVATE UC 52 trial.
Journal: Crohn's & colitis 360
Published: November 26, 2025
Clinical characteristics and treatment pathways of ulcerative colitis patients with isolated proctitis in Europe and the United States.
Journal: Therapeutic advances in gastroenterology
Published: November 11, 2025
Understanding Patient and Gastroenterologist Preferences at the Time of Treatment Escalation to First-Line Advanced Therapy in Ulcerative Colitis: A Discrete Choice Experiment in Five European Countries.
Journal: United European gastroenterology journal
Published: October 17, 2025
Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis in induction and maintenance: systematic literature review and Bayesian network meta-analysis.
Journal: Journal of comparative effectiveness research
Published: March 17, 2025
Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis.
Journal: Journal of comparative effectiveness research
Published: February 24, 2025
Etrasimod Corticosteroid-Free Efficacy, Impact of Concomitant Corticosteroids on Efficacy and Safety, and Corticosteroid-Sparing Effect in Ulcerative Colitis: Analyses of the ELEVATE UC Clinical Program.
Journal: Journal of Crohn's & colitis
Published: April 05, 2024
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme.
Journal: Journal of Crohn's & colitis
Published: November 06, 2023
The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.
Journal: Science (New York, N.Y.)
Published: December 07, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026